Ideas to action: independent research for global prosperity
Search
Filters:
Experts
Facet Toggle
Topics
Facet Toggle
Content Type
Facet Toggle
Publication Type
Facet Toggle
Time Frame
Facet Toggle
Blog Post
March 07, 2023
The EU and its member states are collectively the world’s largest aid donor, with an annual budget of over $70 billion in 2021. When it comes to global health, however, it has historically punched below its weight. In part, this is due to an internal coordination problem; health is a shared competen...
Blog Post
February 13, 2023
Official Development Assistance (ODA) isn’t what it used to be: each aid dollar is worth a lot less in terms of development outcomes. In large part that’s because the Development Assistance Committee (DAC), the donor club within the Organisation for Economic Co-operation and Development (OECD) that ...
Blog Post
February 01, 2023
In December 2022, the international development community gathered in Geneva (and online) for the third High-Level Meeting (HLM) of the Global Partnership for Effective Development Cooperation (GPEDC). In recent years, declining political interest and stalled progress towards effectiveness targets h...
Blog Post
January 25, 2023
Last month, the Center for Global Development (CGD), the White House Office of Science and Technology Policy, and the Office of Management and Budget co-hosted an Evidence Forum as part of the White House Year of Evidence for Action, featuring USAID Administer Samantha Power. The event celebrated pr...
Blog Post
December 21, 2022
If economists are the ‘dismal scientists’ always harping on about limited resources, evaluators are often considered the ‘pessimist scientists’ who only see the half-empty glass, rather than the half-full one. The end of the year is, however, a perfect time to break with that tradition. It is a time...
CGD NOTES
December 14, 2022
Ensuring rapid and equitable access to effective oral COVID-19 therapies is essential to reducing health disparities from COVID-19 and building a better response system for future epidemics and pandemics. A multipronged strategy for medical countermeasures must include antivirals, monoclonal antibod...
Blog Post
December 14, 2022
It’s clear that COVID-19 oral antivirals are effective, and recent deals have made them even cheaper for African countries. But should these countries be investing in these medicines? Or would spending on alternative health services be better value for money? Unfortunately, there is very little avai...
Blog Post
December 14, 2022
Four new CGD pieces, released today, examine the current state of play on COVID-19 oral antivirals. Our analyses provide a deep-dive in key cross-cutting areas—demand, voluntary licensing deals for generic supply, and deployment—and offer policy actions for 2023 and beyond.
Blog Post
December 12, 2022
What’s to love about the Effective Altruism movement (beyond the fact that it is a bunch of people who are committed to working to make things better for others) is that it thinks about everybody worldwide equally when looking for problems to solve. What’s to love a little less is that, when it come...